Page 6 - மரபியல் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Single-cell Analysis Market Size Worth $6 7 Billion By 2028 | CAGR: 15 0%: Grand View Research, Inc

Share this article SAN FRANCISCO, May 17, 2021 /PRNewswire/ The global single-cell analysis market size is expected to reach USD 6.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.0% from 2021 to 2028. Expeditious technological advancements over the years have enabled a comprehensive analysis of transcriptome and genome in an individual cell. Key suggestions from the report: The consumables segment accounted for the largest revenue share due to the high adoption and demand of products offered under this segment Given the wide availability of different forms of reagents, this segment is responsible for constant revenue generation

United statesSouth africaSaudi arabiaSouth koreaSan franciscoAsia pacificMerck milliporeSherry jamesView research incDickinson companyLibrary preparationView researchFluidigm corporationGenomics incIllumina incNovogene corporation

Single-cell Analysis Market Size Worth $6 7 Billion By 2028 | CAGR: 15 0%: Grand View Research, Inc

Single-cell Analysis Market Size Worth $6 7 Billion By 2028 | CAGR: 15 0%: Grand View Research, Inc
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesSouth africaSaudi arabiaSouth koreaGrand viewSan franciscoAsia pacificMerck milliporeSherry jamesView research incDickinson companyLibrary preparationView researchFluidigm corporationGenomics incIllumina inc

Recap: 10x Genomics Q1 Earnings

Quarterly Results Earnings per share rose 186.96% over the past year to $0.66, which beat the estimate of $0.50. Revenue of $231,200,000 higher by 34.42% from the same period last year, which missed the estimate of $232,000,000. Guidance 10x Genomics hasn t issued any revenue guidance for the time being. How To Listen To The Conference Call Date: May 13, 2021

United statesCompany overviewGenomics incInformatics softwareChromium controllerReagent kitsCompatible productsஒன்றுபட்டது மாநிலங்களில்நிறுவனம் ஓவர்‌வ்யூமரபியல் இன்க்தகவல் மென்பொருள்குரோமியம் கட்டுப்படுத்திரீஜெஂட் கருவிகள்

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABBV) - The Daily Biotech Pulse: Merck s Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABBV) - The Daily Biotech Pulse: Merck s Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Puerto ricoSouth africaSouth africanJustis ehlersChemocentryx adcomQuest diagnostics incorporatedArthritis advisory committeeStanford university school of medicineStealth biotherapeutics corpHealth sciences incQuidel corporationInflammation researchPalatin technologies incTherapeutics incGenomics incAbbvie inc

Global Molecular Diagnostics for Cancer Markets Report 2021-2025: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs; COVID-19 Causes Resources Shift

7 Molecular Diagnostics Recent Developments 7.1 Recent Developments - Importance and How to Use This Section 7.1.1 Importance of These Developments 7.1.2 How to Use This Section 7.2 Nucleix to Invest in Early-Stage Lung Cancer Dx 7.3 Invitae to Acquire Genosity for $200M 7.4 Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test 7.5 Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience 7.6 Natera Revenues Grow 35 Percent 7.7 AnchorDx Closes $40M Financing Round 7.8 Exact Sciences Strategy for End-to-End Cancer Testing 7.9 Genomics England: Whole Genome Sequencing for Cancer Patients to Launch 7.10 Singlera Genomics Closes $150M Funding for Cancer Screening 7.11 Biocartis GeneproDx, Endpoint Health Collaborate on Tests for Idylla Platform

United statesNew yorkMiltenyi biotecYourgene elucigeneQiagen gmbhSysmex inosticsBristol myers squibbSiemens healthineersBiocartis geneprodxLaura woodAcademic research labTesting labMdx companion dx developmentSciences strategy for cancer testingTechnology developmentUs medicare expenditures for laboratory testing